What insurance policy changes affect CPT 95923?

There are 8 tracked policy changes affecting CPT 95923, including updates from Anthem BCBS, Humana, Independence Blue Cross. Each change may modify coverage criteria, reimbursement rates, or prior-authorization requirements.

Which payers have updated policy for CPT 95923?

Payers that have issued tracked updates for CPT 95923 include: Anthem BCBS, Humana, Independence Blue Cross.

How do I get notified when CPT 95923 policy changes?

Create a free account at PolicyChanges.app and save a search filtered to CPT 95923. You will receive a daily digest email whenever a new policy change references this code.

Why do payers change policies for CPT 95923?

Payers revise policies for individual billing codes to align with updated clinical guidelines, CMS rule changes, fraud and abuse prevention measures, or network cost-management goals. Changes can affect medical necessity criteria, place-of-service restrictions, bundling rules, or whether a code requires prior authorization.

95923 — A test measuring how well your body's automatic nervous system controls involuntary functions like heart rate and sweating.: Insurance Policy Changes

95923 Insurance Policy Changes

CPT 95923, in plain terms, covers A test measuring how well your body's automatic nervous system controls involuntary functions like heart rate and sweating. CPT 95923 is referenced in 8 tracked payer policy changes from Anthem BCBS, Humana, and 1 other payer. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for CPT 95923 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.

Medium impact

MA07.027h, Autonomic Nervous System Testing

Independence Blue Cross·Effective Mar 4, 2026

Independence Blue Cross reissued MA07.027h on 03/04/2026 to reaffirm the Company's position on autonomic nervous system (ANS) testing. The policy clarifies that ANS testing using noninvasive, portable, automated devices remains experimental/investigational, while formal laboratory-based diagnostic testing is covered only for specific clinical indications. The BILLING REQUIREMENT header has been removed from the policy structure. Billing teams must ensure claims for ANS testing (CPT 95921, 95922, 95923) meet documented medical necessity criteria and are not submitted for screening purposes.

95923 Insurance Policy Changes

[Virginia] Precertification/prior authorization requirement changes

[California] Precertification/prior authorization requirement changes

[California] Precertification/prior authorization requirement changes

Autonomic Nerve Function Testing - Medicare Advantage (Revised)

MA07.027h, Autonomic Nervous System Testing

07.03.23h, Autonomic Nervous System Testing

MA07.027h, Autonomic Nervous System Testing

07.03.23h, Autonomic Nervous System Testing